Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|
holding | GLSH | Common Stock | 16.7M | Jan 13, 2022 | See footnote | F1 |
Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Underlying Class | Amount | Exercise Price | Ownership | Footnotes |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
holding | GLSH | Stock Option (Right to Buy) | Jan 13, 2022 | Common Stock | 77.8K | $4.05 | See footnote | F1, F2 | ||||||
holding | GLSH | Stock Option (Right to Buy) | Jan 13, 2022 | Common Stock | 77.8K | $4.05 | See footnote | F1, F3 | ||||||
holding | GLSH | Stock Warrant | Jan 13, 2022 | Common Stock | 216K | $0.02 | See footnote | F1, F4 | ||||||
holding | GLSH | Earnout Shares | Jan 13, 2022 | Common Stock | 4.53M | See footnote | F1, F5 |
Id | Content |
---|---|
F1 | PureTech Health LLC directly holds all of the securities reported in this Form 3. PureTech Health plc is the parent company of PureTech Health LLC, and has the power to direct the voting and disposition of securities held by PureTech Health LLC. |
F2 | The stock option is currently vested and exercisable. |
F3 | The stock option is currently vested and exercisable. |
F4 | The warrant is currently exercisable. |
F5 | On January 13, 2022, the reporting person received the right to acquire certain shares of the Issuer's Common Stock (the "Earnout Shares") pursuant to the Business Combination Agreement ("BCA") dated as of July 19, 2021, as amended on November 8, 2021, by and among Capstar Special Purpose Acquisition Corp., CPSR Merger Sub and Gelesis, Inc. ("Private Gelesis"). The Earnout Shares shall vest and be released upon the satisfaction of certain share price vesting conditions prior to January 13, 2027, as set forth in the BCA. |